
Sign up to save your podcasts
Or


A surgeon in burns reconstruction, Matt Klein swapped the operating room for the equally high-pressure environment of drug development. In this episode of Pathfinders in Biopharma, he sets out the vision for the company he now leads, PTC Therapeutics – a pioneer in the field of RNA therapies, now powering towards profitability with treatment candidates for a host of rare diseases.
By RBC Capital Markets5
1212 ratings
A surgeon in burns reconstruction, Matt Klein swapped the operating room for the equally high-pressure environment of drug development. In this episode of Pathfinders in Biopharma, he sets out the vision for the company he now leads, PTC Therapeutics – a pioneer in the field of RNA therapies, now powering towards profitability with treatment candidates for a host of rare diseases.

3,221 Listeners

1,720 Listeners

973 Listeners

1,898 Listeners

1,640 Listeners

1,101 Listeners

123 Listeners

324 Listeners

1,041 Listeners

1,307 Listeners

6,076 Listeners

34 Listeners

40 Listeners

19 Listeners

10 Listeners

0 Listeners

74 Listeners

18 Listeners

15 Listeners

3 Listeners